Administrative Rules of Montana
Department 24 - LABOR AND INDUSTRY
Chapter 24.165 - BOARD OF OCCUPATIONAL THERAPY PRACTICE
Subchapter 24.165.5 - Licensing and Scope of Practice
Rule 24.165.522 - ADRENOCORTICO-STEROID AGENTS PROTOCOLS
Current through Register Vol. 18, September 20, 2024
(1) Clinicians may use adrenocortico-steroid agents as directed by a licensed medical practitioner with prescriptive authority.
(2) Adrenocortico-steroid agents act by diffusing across cell membranes to combine with specific cytoplasmic receptors. The resulting complexes enter the nucleus and bind to DNA, thereby irritating cytoplasmic synthesis of the enzymes responsible for systemic effects of adrenocortico-steroids.
(3) Adrenocortico-steroid agents are indicated for inflammation ( including but not limited to tendonitis, bursitis, arthritis, or myositis), and for antipruritic and vasoconstrictor actions.
(4) Adrenocortico-steroid agents are contraindicated or require special care when used with children, growing adolescents, and pregnant women. Adrenocortico-steroid agents are also contraindicated:
(5) The adrenocortico-steroid agents permitted by this rule are:
AUTH: 37-24-201, 37-24-202, MCA IMP: 37-24-108, 37-24-109, MCA